<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteGenetics &#8211; Wyss Institute</title>
		<link>https://wyss.harvard.edu</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Fri, 03 Apr 2026 13:05:52 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.harvard.edu/discipline/genetics/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.7.1</generator>

		<!-- Start loop -->
		
			<item>
				<title>Toward autonomous self-organizing biological robots with a nervous system</title>
				<link>https://wyss.harvard.edu/news/toward-autonomous-self-organizing-biological-robots-with-a-nervous-system/</link>
        <pubDate>Mon, 16 Mar 2026 18:30:42 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Bioinspired Robotics]]></category>
		<category><![CDATA[Brain Health]]></category>
		<category><![CDATA[Brain Injury]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Gene Regulation]]></category>
		<category><![CDATA[Michael Levin]]></category>
		<category><![CDATA[Neuroscience]]></category>
		<category><![CDATA[Stem Cells]]></category>
		<category><![CDATA[Tufts University]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44996</guid>
                            <description>In a first-of-its-kind study, researchers demonstrate that functional nervous systems can form within self-organized living cellular robots, conferring complex movement patterns and distinct gene expression profiles</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Biobots, whose growing line of variants started with Xenobots, are fascinating tiny self&#x2d;powered living robots built exclusively using frog embryonic cells. Originally developed in the laboratories of Wyss Institute Associate Faculty member and Tufts University Professor Michael Levin, Ph.D. and his collaborators at University of Vermont&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/toward-autonomous-self-organizing-biological-robots-with-a-nervous-system/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/toward-autonomous-self-organizing-biological-robots-with-a-nervous-system/</link>
          <title>The team made an important step towards creating self-organizing biological robots with a functional nervous system. As can be seen in this image, neurobots are made of an outer surface consisting of multicilliated cells, mucus-secreting goblet cells, ionocytes, and small secretory cells, and a nervous system that reaches out to surface cells underneath. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/03/09141311/Neurobot-cover-image-e1773080011693.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=1fb2c1abf80eec239961949d4dffbf6e"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Institute appoints three new Associate Faculty members: Ahmad Khalil, Jarad Mason, and Ting Wu</title>
				<link>https://wyss.harvard.edu/news/wyss-institute-appoints-three-new-associate-faculty-members-ahmad-khalil-jarad-mason-and-ting-wu/</link>
        <pubDate>Mon, 08 Dec 2025 14:50:20 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Ahmad (Mo) Khalil]]></category>
		<category><![CDATA[Faculty of Arts and Sciences]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Jarad Mason]]></category>
		<category><![CDATA[Ting Wu]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44386</guid>
                            <description>These three distinguished researchers bring their expertise in synthetic biology, materials science, and genome research to contribute to the Institute’s mission of societal impact</description>
                                        <content:encoded><![CDATA[<p>By Jessica Leff The Wyss Institute is proud to welcome three new Associate Faculty members: Ahmad (Mo) Khalil, Ph.D., Jarad Mason, Ph.D., and Chao&#x2d;ting (Ting) Wu, Ph.D. Each has a history of collaborating with the Institute&rsquo;s researchers. Their diverse expertise and fresh perspectives will further strengthen the Wyss&rsquo; innovative and collaborative ecosystem and enable pioneering advances in&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/wyss-institute-appoints-three-new-associate-faculty-members-ahmad-khalil-jarad-mason-and-ting-wu/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/wyss-institute-appoints-three-new-associate-faculty-members-ahmad-khalil-jarad-mason-and-ting-wu/</link>
          <title>The Wyss welcomed <a href="https://wyss.harvard.edu/news/wyss-institute-appoints-three-new-associate-faculty-members-ahmad-khalil-jarad-mason-and-ting-wu/"> three new Associate Faculty members, Ahmad Khalil, Ph.D., Jarad Mason, Ph.D., and Chao-ting (Ting) Wu, Ph.D.</a> They are bringing expertise in synthetic biology, materials science, and genome research. Credit: Wyss Institute at Harvard University </title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/12/04113526/New-Associate-Faculty-Listing-Image-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=ebaa61d75da3e2378cc130527161cb3e"/></url>
				</image>
        			</item>

		
			<item>
				<title>How federal funds fuel life-saving innovation</title>
				<link>https://wyss.harvard.edu/news/how-federal-funds-fuel-life-saving-innovation/</link>
        <pubDate>Thu, 20 Nov 2025 17:49:40 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[David Paydarfar]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44198</guid>
                            <description>Foundational breakthroughs enabled by government research grants lead to technologies changing patients’ lives for the better</description>
                                        <content:encoded><![CDATA[<p></p>
<p><a href="https://wyss.harvard.edu/news/how-federal-funds-fuel-life-saving-innovation/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/how-federal-funds-fuel-life-saving-innovation/</link>
          <title>Researchers put a lot of effort into preparing extensive grant applications, which then go through a lengthy review process. A small percentage receive funding. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/11/12163644/Kiley-Baker-and-Keysa-Garcia-Candid-Color-Corrected_04289-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=93f76f74996be3212132d618d4328d19"/></url>
				</image>
        			</item>

		
			<item>
				<title>George Church on Widespread Genomic Sequencing, Xenotransplantation, and Shepherding Change</title>
				<link>https://wyss.harvard.edu/media-post/george-church-on-widespread-genomic-sequencing-xenotransplantation-and-shepherding-change/</link>
        <pubDate>Mon, 17 Nov 2025 20:46:55 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[eGenesis]]></category>
		<category><![CDATA[George Church]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=44304</guid>
                                                <content:encoded><![CDATA[<p>In this interview, GenomeWeb speaks to Core Faculty member George Church, Ph.D., who is also a professor at Harvard Medical School and the Harvard&#x2d;MIT Program in Health Sciences and Technology. A thinker, inventor, and collaborator extraordinaire, Church&rsquo;s technologies and personality catalyzed the Human Genome Project, the Personal Genome Project, and more than 50 biotech startups&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/george-church-on-widespread-genomic-sequencing-xenotransplantation-and-shepherding-change/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/george-church-on-widespread-genomic-sequencing-xenotransplantation-and-shepherding-change/</link>
          <title>George Church</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2016/08/05095301/George_Church_headshot_1500x1000.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=57b357a30a9a206e8ff5c6444955b65e"/></url>
				</image>
        			</item>

		
			<item>
				<title>Highly Cited Researchers 2025 honors nine Wyss members</title>
				<link>https://wyss.harvard.edu/news/highly-cited-researchers-2025-honors-nine-wyss-members/</link>
        <pubDate>Mon, 17 Nov 2025 18:50:51 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Conor Walsh]]></category>
		<category><![CDATA[David A. Weitz]]></category>
		<category><![CDATA[David Mooney]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44258</guid>
                            <description>The annual award celebrates the top 1% of researchers by paper citations over the last decade</description>
                                        <content:encoded><![CDATA[<p>By Alexandra Jirstrand (BOSTON) &ndash; Clarivate Analytics announced its Highly Cited Researchers 2025 list, which honors the top 1% of researchers around the world whose papers have been cited the most over the last decade. Clarivate uses both quantitative and qualitative analyses to identify individuals who have demonstrated significant and broad influence in their chosen field(s) of research.</p>
<p><a href="https://wyss.harvard.edu/news/highly-cited-researchers-2025-honors-nine-wyss-members/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/highly-cited-researchers-2025-honors-nine-wyss-members/</link>
          <title>Nine Wyss faculty and staff members were recognized as Highly Cited Researchers. Credit: Envato Elements/GoldenDayz</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/11/17111618/backlit-group-of-businesspeople-standing-on-light-2025-10-15-05-24-04-utc-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=a9cd3f2fec64943b203ad4b0146d74c5"/></url>
				</image>
        			</item>

		
			<item>
				<title>Recapitulating egg and sperm development in the dish</title>
				<link>https://wyss.harvard.edu/news/recapitulating-egg-and-sperm-development-in-the-dish/</link>
        <pubDate>Fri, 15 Aug 2025 17:55:46 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Anti-aging]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[DNA sequencing]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Gene Regulation]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43314</guid>
                            <description>New stem cell differentiation method is first to induce meiosis, a critical step in egg and sperm cell development, with potential for drug development and future fertility treatments</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; More than one&#x2d;sixth of adults around the world experience infertility in their lifetime. There is a high unmet need not only for increased access to affordable, high&#x2d;quality fertility care for those in need but, importantly, also for new biomedical solutions that can address the root causes of infertility. Some of the earliest causes of infertility go back to&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/recapitulating-egg-and-sperm-development-in-the-dish/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/recapitulating-egg-and-sperm-development-in-the-dish/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/07/16122007/Meiotic-features-in-iPSC-derived-cells-induced-to-differentiate-as-eggs-and-sperm_feature.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=025fe719d7e73d34266007ebf246a369"/></url>
				</image>
        			</item>

		
			<item>
				<title>The Wyss Institute’s 2025-2026 Validation Projects</title>
				<link>https://wyss.harvard.edu/news/the-wyss-institutes-2025-2026-validation-projects/</link>
        <pubDate>Thu, 14 Aug 2025 15:00:53 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43463</guid>
                            <description>14 teams supported this year to advance projects with future potential for real-world impact through the Wyss’ technology innovation funnel</description>
                                        <content:encoded><![CDATA[<p>Throughout recent years, the Wyss&rsquo; Validation Project mechanism has proven to be a highly valuable instrument for selecting and kick&#x2d;starting projects with early potential for positive impact on healthcare and the environment. Reaching deep into areas with major unmet needs across the diverse Grand Challenges laid out by the Institute, the newly selected projects are driven by multi&#x2d;talented teams&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/the-wyss-institutes-2025-2026-validation-projects/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/the-wyss-institutes-2025-2026-validation-projects/</link>
          <title>Senior Scientist Kwasi Adu-Berchie (center) is leading the TIB project team with Core Faculty member David Mooney (left). The team is developing tolerance-inducing biomaterials to offer patients safer, longer-lasting treatments for conditions ranging from autoimmune disease to tissue and bone injury. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/08/13101608/Dave-Mooney-Lab-Candid-Lab-Coat-07873-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=b0631ddd4c73659862b34b403e537e4f"/></url>
				</image>
        			</item>

		
			<item>
				<title>George Church: Embracing Outliers in Science and in Life</title>
				<link>https://wyss.harvard.edu/media-post/george-church-embracing-outliers-in-science-and-in-life/</link>
        <pubDate>Fri, 25 Jul 2025 13:38:53 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Entrepreneurship]]></category>
		<category><![CDATA[George Church]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=43361</guid>
                                                <content:encoded><![CDATA[<p>George Church, Ph.D., is a Core Faculty member at the Wyss Institute and a genetics professor at Harvard Medical School. He is a pioneer in synthetic biology and personalized genomics. In 2017, Time magazine named him as one of the 100 most influential people in the world. In addition to being a scientist, Church is also a prolific serial entrepreneur. He has co&#x2d;founded over 50 biotech startups&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/george-church-embracing-outliers-in-science-and-in-life/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/george-church-embracing-outliers-in-science-and-in-life/</link>
          <title>George Church</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2016/08/05095301/George_Church_headshot_1500x1000.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=57b357a30a9a206e8ff5c6444955b65e"/></url>
				</image>
        			</item>

		
			<item>
				<title>Forging a novel therapeutic path for patients with Rett Syndrome using AI</title>
				<link>https://wyss.harvard.edu/news/forging-a-novel-therapeutic-path-for-patients-with-rett-syndrome-with-ai/</link>
        <pubDate>Wed, 02 Jul 2025 13:55:03 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[CRISPR]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Michael Levin]]></category>
		<category><![CDATA[Systems Biology]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43198</guid>
                            <description>AI-enabled drug discovery approach identified potentially game-changing treatment, which has been advanced from the lab bench to an FDA Orphan Drug Designation in record time</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Rett syndrome is a devastating, rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it, and much fewer boys. It is caused by mutations in the MeCP2 gene on the X chromosome, leading to a spectrum of cognitive and physical impairments, including repetitive hand motions, speech difficulties, and seizures. However&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/forging-a-novel-therapeutic-path-for-patients-with-rett-syndrome-with-ai/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/forging-a-novel-therapeutic-path-for-patients-with-rett-syndrome-with-ai/</link>
          <title>Tiffany Lin, Magnificent Microscopy, RUNNER UP: Multi-photon image of entire <em>Xenopus</em> brain (Dorsal)</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2022/08/17171224/Photo10.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=158196cf8e816cae4e6fed32e5afb2f5"/></url>
				</image>
        			</item>

		
			<item>
				<title>Toward recreating the brain’s immune system in a dish</title>
				<link>https://wyss.harvard.edu/news/toward-recreating-the-brains-immune-system-in-a-dish/</link>
        <pubDate>Tue, 10 Jun 2025 13:55:59 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Amyotrophic Lateral Sclerosis (ALS)]]></category>
		<category><![CDATA[Brain Health]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Inflammation]]></category>
		<category><![CDATA[Multiple Sclerosis (MS)]]></category>
		<category><![CDATA[Neurology]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=42979</guid>
                            <description>Advanced stem cell differentiation platform and synthetic biology enable <em>in vitro</em> production of human microglia cells and new opportunities for brain research and therapeutic developments</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; &shy;Microglia are a specialized type of immune cells that accounts for about 10% of all cells within the brain and spinal cord. They function by eliminating infectious microbes, dead cells, and aggregated proteins, as well as soluble antigens that may endanger the brain and, during development, also help shape neural circuits enabling specific brain functions.</p>
<p><a href="https://wyss.harvard.edu/news/toward-recreating-the-brains-immune-system-in-a-dish/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/toward-recreating-the-brains-immune-system-in-a-dish/</link>
          <title>Microglia cells are brain-specific immune cells that play an important role in the process of “neuroinflammation” as well as the removal of dead and damaged cells, and pathogenic aggregates. Overcoming a major bottleneck in the modeling of neurological disorders, the Wyss team as engineered an effective and fast way to create human microglia-like cells <em>in vitro</em>. Credit:  </title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/06/09131626/Brain-inflammation.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=254a7a4e4d0f36cb9f5f6846526323da"/></url>
				</image>
        			</item>

			</channel>
</rss>
